In conclusion, CPX displays antileukemia effect on both GC-sensitive and GC- resistant T-ALL cells, and this is closely correlated with downregulation of intracellular ferritin expression and inhibition of the β-catein-c-Myc signaling pathway. This evidence concerns the gene MYC and acute lymphoblastic leukemia.